Viral gene expression in B95-8 and B27-BMRF-2low cells. A. The ratio of recombinant EBV to WT EBV in B27-BMRF-2low cells. Total EBV copy numbers were quantitated using the BZLF-1 probe and recombinant virions were quantitated by the NK probe, numbers represent the percentages of total viral genome copy numbers. B. RT-PCR detection of BMRF-1, BMRF-2, and BZLF-1 expression in B95-8 and B27-BMRF-2low cells. 5 × 106 each of B95-8 and B27-BMRF-2low cells were treated with or without PMA (30 ng/ml) for 5 days before total RNA was extracted. Five μl of cDNA (out of 20 μl reaction) were used as PCR templates. The top panel shows expression of both BMRF-2 and BZLF-1 in the same PCR reaction. The bottom panel shows expression of the BMRF-1 gene. C. Western blot analysis showing BMRF-2, gp350/220, and BMRF-1 expression in B95-8 and B27-BMRF-2low cells. For BMRF-2 and gp350 detection, 10 μg of the membrane fraction proteins were loaded onto each well of a 7 M urea SDS-PAGE gel. BMRF-1 was detected using total cell lysates separated on a NuPage 10% Bis-Tris gel. D. Western blot detection of EBNA-1 and β-actin expression in noninduced B95-8 and B27-BMRF-2low cells. 10 μg of total cell lysates were loaded onto each well in a NuPage 10% Bis-Tris gel. The mean density of pixels of the protein bands shown in panels C and D were measured by the NIH Image software, and the results of each gel are shown as a bar graph under each blot and background values were subtracted from each protein band. E. Cell surface detection of BMRF-2 by flow cytometry in B95-8 and B27-BMRF-2low cells using rat anti–BMRF-2 serum. Histograms are labeled as the following: 1, normal rat serum staining of these two cell lines (since the histograms were almost identical, only one is shown); 2, B27-BMRF-2low cells reacted with rat anti-BMRF-2 serum; 3, B95-8 cells reacted with rat anti-BMRF-2 serum. MN, mean fluorescence intensity.